EP2894151
IMÍDASÓLÍN AFLEIÐUR, AÐFERÐIR TIL FRAMLEIÐSLU ÞEIRRA OG NOTKUN ÞEIRRA VIÐ LÆKNINGAR
:
EP einkaleyfi í gildi á Íslandi:
26.8.2013:
11.11.2020:
13835193.7
:
4.1.2021:
15.2.2021
:
25.8.2033:
25.8.2026:
31.8.2026
:
IMIDAZOLINE DERIVATIVES, PREPARATION METHODS THEREOF, AND THEIR APPLICATIONS IN MEDICINE
26.8.2013
11.11.2020
4.1.2021
15.2.2021
25.8.2026
:
Shanghai Hengrui Pharmaceutical Co. Ltd.:
279 Wenjing Road, Minhang District Shanghai 200245, CN
:
Jiangsu Hengrui Medicine Co. Ltd.:
No. 7 Kunlunshan Road Economic and Technological Development Zone Lianyungang, Jiangsu 222047, CN
:
LU, Hejun:
Shanghai 200245, CN
:
SUN, Piaoyang:
Lianyungang Jiangsu 222047, CN
:
FEI, Hongbo:
Shanghai 200245, CN
:
JIANG, Hongjian:
Shanghai 200245, CN
:
WANG, Haowei:
Shanghai 200245, CN
:
DONG, Qing:
Shanghai 200245, CN
:
Novagraaf Brevets:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
:
201210323870:
4.9.2012:
CN
:
CN2013082273:
26.8.2013
:
C07D 233/72, C07D 233/84, C07D 233/86, A61K 31/4164, A61K 31/4166, A61K 31/4178, A61P 5/28, A61P 35/00
: 9
: 10.8.2021
: 25.8.2022
: Árnason Faktor ehf.
: 10
: 13.7.2022
: 25.8.2023
: Acumass
: 11
: 19.7.2023
: 25.8.2024
: Acumass
: 12
: 17.7.2024
: 25.8.2025
: Acumass
: 13
: 18.7.2025
: 25.8.2026
: Acumass